News Archive
Displaying the 10 most recent press releases...
Wednesday, May 15, 2013
EntreMed Reports First Quarter 2013 Financial Results
Monday, May 6, 2013
Patent Issued In China For EntreMed’s Lead Drug Candidate ENMD-2076
Friday, May 3, 2013
Patent Issued In U.S. For EntreMed’s 2ME2 In Rheumatoid Diseases
Friday, April 5, 2013
EntreMed Announces Changes to Board of Directors and CEO Appointment
Thursday, March 21, 2013
EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
Friday, March 1, 2013
EntreMed to Raise $10.7 Million in Registered Direct Offering
Wednesday, January 23, 2013
EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
Monday, January 7, 2013
EntreMed Files New Drug Clinical Trial Application For ENMD-2076 With China SFDA To Advance Global Development Strategy
Friday, January 4, 2013
EntreMed Announces Initiation Of Second Site For Phase 2 Trial In Triple-Negative Breast Cancer
Tuesday, December 4, 2012
PNAS Publishes Preclinical Results of EntreMed’s 2ME2 for Multiple Sclerosis